-
Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters
Pedreño-Lopez, N; Tarrés-Freixas, F; Usai, C; Raïch-Regué, D; Benet, S; Ainsua-Enrich, E; Carabelli, J; Pradenas, E; Avila-Nieto, C; Roca, N;...
-
Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model
Ruiz-Casas, C; Tarrés-Freixas, F; Roca, N; Pérez, M; Cantero, G; Martín, L; Olvera, A; Ruiz-Riol, M; Brander, C; Usai, C; Vergara-Alert, J;...
-
Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model
Ruiz-Casas, Carla; Tarres-Freixas, Ferran; Roca, Nuria; Perez, Monica; Cantero, Guillermo; Martin, Laura; Olvera, Alex; Ruiz-Riol, Marta; Brander,...
-
Porcine nasal organoids to model interactions between the swine nasal microbiota and the host
Bonillo-Lopez, L; Carmona-Vicente, N; Tarres-Freixas, F; Kochanowski, K; Martinez, J; Perez, M; Sibila, M; Correa-Fiz, F; Aragon, V
-
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model
Pons-Grifols, Anna; Tarres-Freixas, Ferran; Perez, Monica; Riveira-Munoz, Eva; Raich-Regue, Dalia; Perez-Zsolt, Daniel; Munoz-Basagoiti, Jordana;...
-
Subcutaneous administration of an endocrine-mimetic, slow-release protein material reduces the severity of SARS-CoV-2 infection
Parlade, Eloi; Tarres-Freixas, Ferran; Favaro, Marianna T P; Lascorz, Jara; Marquez-Matinez, Merce; Mendoza, Rosa; Corchero, Jose Luis; Cantero,...
-
An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters
Foederl-Hoebenreich, Esther; Izadi, Shiva; Hofacker, Lara; Kienzl, Nikolaus F; Castilho, Alexandra; Strasser, Richard; Tarres-Freixas, Ferran;...
-
Improvements in RNA and DNA nanopore sequencing allow for rapid genetic characterization of avian influenza
Perlas, Albert; Reska, Tim; Croville, Guillaume; Tarres-Freixas, Ferran; Guerin, Jean-Luc; Majo, Natalia; Urban, Lara
-
Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes
Molina, Elisa Molina; Bech-Serra, Joan Josep; Franco-Trepat, Eloi; Jarne, Ignasi; Perez-Zsolt, Daniel; Badia, Roger; Riveira-Munoz, Eva;...
-
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection
Avila-Nieto, C; Vergara-Alert, J; Amengual-Rigo, P; Ainsua-Enrich, E; Brustolin, M; de la Concepción, MLR; Pedreño-Lopez, N; Rodon, J; Urrea, V;...
-
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models
Usai, C; Ainsua-Enrich, E; Gales, VU; Pradenas, E; Lorca-Oró, C; Tarrés-Freixas, F; Roca, N; Pérez, M; Avila-Nieto, C; de la Concepción, MLR;...
-
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity
de Campos-Mata, L; Trinité, B; Modrego, A; Vaquero, ST; Pradenas, E; Pons-Grífols, A; Melero, NR; Carlero, D; Marfil, S; Santiago, C;...
-
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant
Avila-Nieto, C; Vergara-Alert, J; Amengual-Rigo, P; Ainsua-Enrich, E; Brustolin, M; de la Concepción, MLR; Pedreño-Lopez, N; Rodon, J; Urrea, V;...
-
Beta-Cyclodextrins as affordable antivirals to treat coronavirus infection
Raïch-Regué, D; Tenorio, R; de Castro, IF; Tarrés-Freixas, F; Sachse, M; Perez-Zsolt, D; Muñoz-Basagoiti, J; Fernández-Sánchez, SY; Gallemi, M;...
-
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
Tarrés-Freixas, F; Trinité, B; Pons-Grífols, A; Romero-Durana, M; Riveira-Muñoz, E; Avila-Nieto, C; Pérez, M; Garcia-Vidal, E; Perez-Zsolt, D;...
-
Clinical course impacts early kinetics, magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
Pradenas, E; Trinité, B; Urrea, V; Marfil, S; Tarres-Freixas, F; Ortiz, R; Rovirosa, C; Rodon, J; Vergara-Alert, J; Segalées, J; Guallar, V;...
-
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Trinité, B; Pradenas, E; Marfil, S; Rovirosa, C; Urrea, V; Tarrés-Freixas, F; Ortiz, R; Rodon, J; Vergara-Alert, J; Segalés, J; Guallar, V;...
-
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Pradenas, E; Trinité, B; Urrea, V; Marfil, S; Avila-Nieto, C; de la Concepción, MLR; Tarrés-Freixas, F; Pérez-Yanes, S; Rovirosa, C;...
-
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
Trinité, B; Tarrés-Freixas, F; Rodon, J; Pradenas, E; Urrea, V; Marfl, S; de la Concepción, MLR; Avila-Nieto, C; Aguilar-Gurrieri, C; Barajas, A;...
